Finally, additional studies using dynamic contrast-enhanced MRI and PET, for example targeting P-glycoprotein-mediated efflux at the BBB, are needed to elucidate the temporal contribution of BBB impairment to delirium. The gene discussed is ABCB1; the disease is delirium.